The Canadian Cancer Society urges governments to lower the colorectal cancer screening age to 45 as diagnoses continue rising among Canadians under 50.
Health Canada expands Ozempic approval to include reducing the risk of heart attacks and strokes in adults with type 2 diabetes and heart or kidney disease.